
    
      A randomized controlled clinical trial will be used to test the efficacy of this brief CBT-I
      compared to attention control on sleep, mood, functional status and quality of life in lung
      cancer survivors and evaluate the feasibility of translating an evidence-based CBT-I into the
      clinical setting.
    
  